Evidence map›Paper›PMID 34305931›Full record

ArticleFrontiers in immunology2021

An Unbiased Machine Learning Exploration Reveals Gene Sets Predictive of Allograft Tolerance After Kidney Transplantation.

Qiang Fu, Divyansh Agarwal, Kevin Deng, Rudy Matheson, Hongji Yang, Liang Wei, Qing Ran, Shaoping Deng, James F Markmann

Open access · goldAbstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Properties of regulatory B cells regulating B cell targets.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Qiang FuOrgan Transplantation Center, Sichuan Provincial People's Hospital and School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Divyansh AgarwalDivision of Transplantation, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, United States.
Kevin DengCenter for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Rudy MathesonCenter for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Hongji YangOrgan Transplantation Center, Sichuan Provincial People's Hospital and School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Liang WeiOrgan Transplantation Center, Sichuan Provincial People's Hospital and School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Qing RanOrgan Transplantation Center, Sichuan Provincial People's Hospital and School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Shaoping DengOrgan Transplantation Center, Sichuan Provincial People's Hospital and School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
James F MarkmannCenter for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
University of Electronic Science and Technology of China · CNHarvard University · USMassachusetts General Hospital · USHospital of the University of Pennsylvania · US

Funding

Mechanisms of B Cell-Dependent Transplantation ToleranceR01AI057851 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI JAMES FRANCIS MARKMANN · 2006 to 2026
$8.9M
NIAID NIH HHS R01 AI057851
6 · The paper itself

Abstract

Efforts at finding potential biomarkers of tolerance after kidney transplantation have been hindered by limited sample size, as well as the complicated mechanisms underlying tolerance and the potential risk of rejection after immunosuppressant withdrawal. In this work, three different publicly available genome-wide expression data sets of peripheral blood lymphocyte (PBL) from 63 tolerant patients were used to compare 14 different machine learning models for their ability to predict spontaneous kidney graft tolerance. We found that the Best Subset Selection (BSS) regression approach was the most powerful with a sensitivity of 91.7% and a specificity of 93.8% in the test group, and a specificity of 86.1% and a sensitivity of 80% in the validation group. A feature set with five genes (HLA-DOA, TCL1A, EBF1, CD79B, and PNOC) was identified using the BSS model. EBF1 downregulation was also an independent factor predictive of graft rejection and graft loss. An AUC value of 84.4% was achieved using the two-gene signature (EBF1 and HLA-DOA) as an input to our classifier. Overall, our systematic machine learning exploration suggests novel biological targets that might affect tolerance to renal allografts, and provides clinical insights that can potentially guide patient selection for immunosuppressant withdrawal.

Indexed as

Gene Expression ProfilingKidney TransplantationMachine LearningTranscriptomeClinical Decision-MakingDatabases, GeneticGraft RejectionGraft SurvivalHumansImmunosuppressive AgentsOligonucleotide Array Sequence AnalysisPatient SelectionPredictive Value of TestsRisk AssessmentRisk FactorsTime FactorsImmunosuppressive Agentsbiomarkerkidney transplantationmachine learningPBMCtolerance

Identifiers

PMID34305931
PMCPMC8297499
OpenAlexW3182606315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.